Evidence map›Paper›PMID 12061892›Full record

ArticleThe Biochemical journal2002

A 13C-NMR study of the inhibition of papain by a dipeptide-glyoxal inhibitor.

Jonathan Lowther, Aleksandra Djurdjevic-Pahl, Chandralal Hewage, J Paul G Malthouse

Open access · bronzeAbstract read
In one paragraph

Article in The Biochemical journal, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jonathan LowtherDepartment of Biochemistry and Centre for Synthesis and Chemical Biology, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Ireland.
Aleksandra Djurdjevic-Pahl
Chandralal Hewage
J Paul G Malthouse
University College Dublin · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Z-Phe-Ala-glyoxal (where Z is benzyloxycarbonyl) has been synthesized and shown to be a competitive inhibitor of papain with a K(i)=3.30+/-0.25 nM. (13)C-NMR has been used to show that in aqueous media, Z-Phe-[2-(13)C]Ala-glyoxal gives signals at 207.7 p.p.m. and 96.3 p.p.m. showing that both the alpha-keto carbon and its hydrate are present. When this inhibitor is bound to papain a single signal at 209.7 p.p.m. is observed due to the (13)C-enriched carbon. This demonstrates that the glyoxal alpha-keto carbon is not hydrated when it is bound to papain and that it does not form a thiohemiketal with the thiol group of Cys-25. Z-Phe-[1-(13)C]Ala-glyoxal has also been synthesized and its aldehyde carbon is fully hydrated in aqueous solution giving signals at 88.7 p.p.m. and 90.2 p.p.m. when the alpha-keto carbon and its hydrate are present respectively. When this inhibitor is bound to papain a single signal at 71.04 p.p.m. was observed due to the (13)C-enriched carbon showing that the (13)C-enriched aldehyde carbon forms a thiohemiacetal with Cys-25.

Indexed as

AlanineCatalysisCysteineDipeptidesGlyoxalMagnetic Resonance SpectroscopyModels, ChemicalPapainPhenylalanineSulfhydryl CompoundsAlanineCysteineDipeptidesGlyoxalPapainPhenylalanineSulfhydryl Compounds

Identifiers

PMID12061892
PMCPMC1222827
OpenAlexW2002532427

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.